ODYS

Odysight is a sub-scale story stock, not yet an investable business. FY2025 revenue was just $3.02M and it went backwards 23.9% YoY (from $3.96M), while net loss widened 44.8% to -$17.0M and operating margin sits at -601.5%. Gross profit is a rounding error ($871K on a 28.9% gross margin), and the accumulated deficit has reached -$63.0M. Revenue this small and this volatile (it has bounced $3.03M → $3.96M → $3.02M over three years) gives no evidence of a durable, scaling commercial model, despite marquee logos cited in the MD&A (Israeli Air Force/MoD, NASA, Israel Railways, a European elevator-monitoring provider). R&D spend (+40% to $9.64M) now dwarfs revenue 3-to-1 — this is a development-stage bet on visual predictive-maintenance AI, not a company you value on its current P&L.

The valuation makes that bet untenable at today's price. A $68.2M market cap on $3.02M of declining revenue is 22.6x sales — a multiple normally reserved for fast-growing software, applied here to a business whose top line is contracting and whose losses are accelerating. There is no earnings, no positive cash flow, and no growth to anchor the multiple to. The one genuine strength is the balance sheet: $25.7M cash, total liabilities of only $3.55M (0.14x equity), and essentially no debt, courtesy of the February 2025 Nasdaq uplisting and public offering that raised ~$20.9M net at $6.50/share. But operating cash flow was -$13.7M in FY2025, implying roughly 1.5–2 years of runway before another capital raise — and with the stock now at $4.17 (well below the $6.50 offering price), the next raise would be dilutive on worse terms.